Mackay Shields LLC has filed its 13F form on April 28, 2025 for Q1 2025 where it was disclosed a total value porftolio of $514 Million distributed in 361 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuveen Amt Free Quality Municipal Income Fund with a value of $44.8M, Ishares Gold Trust with a value of $38.9M, Nuveen Municipal Credit Income Fund with a value of $36.4M, Black Rock Municipal 2030 Target Term Trust with a value of $33.2M, and Talos Energy Inc. with a value of $30.4M.
Examining the 13F form we can see an increase of $14.8M in the current position value, from $499M to 514M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$514 Million
$388 Million
$58.6 Million
$43.3 Million
$15.7 Million
$7.18 Million
$404,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2025
Added 14.11%
-
$0
0.0% of portfolio
-
Q3 2024
Added 3,038.26%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.96%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 39.16%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 67.77%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 5.13%
-
$0
0.0% of portfolio
-
Q1 2025
Added 29.34%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.93%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.33%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 14.03%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.99%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.19%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.37%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.53%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.71%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 45.97%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 3.05%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 2.48%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.15%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 56.52%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.82%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 2.24%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.44%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.51%
-
$0
0.0% of portfolio
-
Q4 2024
Added 0.1%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2024
New
Solaredge Technologies Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 50.32%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 4.17%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 10.05%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.44%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.51%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 43.46%
-
$0
0.0% of portfolio
-
Q1 2024
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 5.01%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 0.61%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.48%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.64%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 1.23%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 12.01%
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 99.77%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 38.09%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 41.3%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 4.15%
